141 related articles for article (PubMed ID: 11023397)
1. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.
Drewe E; McDermott EM; Powell RJ
N Engl J Med; 2000 Oct; 343(14):1044-5. PubMed ID: 11023397
[No Abstract] [Full Text] [Related]
2. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
[TBL] [Abstract][Full Text] [Related]
3. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
[TBL] [Abstract][Full Text] [Related]
4. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
Smith GR; Tymms KE; Falk M
Intern Med J; 2004; 34(9-10):570-2. PubMed ID: 15482271
[TBL] [Abstract][Full Text] [Related]
5. Hereditary periodic fever.
Hull KM; Kastner DL; Balow JE
N Engl J Med; 2002 May; 346(18):1415-6; author reply 1415-6. PubMed ID: 11986423
[No Abstract] [Full Text] [Related]
6. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
7. First report of rapidly progressive glomerulonephritis in tumor necrosis factor receptor-associated periodic syndrome.
Harambat J; Desjonqueres M; Garaix F; Cochat P; Ranchin B; Cimaz R; Dodé C; Bouvier R
Arthritis Rheum; 2008 Oct; 58(10):3275-6. PubMed ID: 18821681
[No Abstract] [Full Text] [Related]
8. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.
Kallinich T; Briese S; Roesler J; Rudolph B; Sarioglu N; Blankenstein O; Keitzer R; Querfeld U; Haffner D
J Rheumatol; 2004 Dec; 31(12):2519-22. PubMed ID: 15570662
[TBL] [Abstract][Full Text] [Related]
9. Colchicine therapy for nephrotic syndrome due to familial Mediterranean fever.
Skrinskas G; Bear RA; Magil A; Lee KY
Can Med Assoc J; 1977 Dec; 117(12):1416-7. PubMed ID: 589544
[No Abstract] [Full Text] [Related]
10. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease.
Serratrice J; Granel B; Disdier P; Weiller PJ; Dussol B
Am J Med; 2003 Nov; 115(7):589-90. PubMed ID: 14599647
[No Abstract] [Full Text] [Related]
11. Familial Mediterranean fever and nephrotic syndrome in Turkey.
Erek E; Onen K; Müftüoğlu A; Ulkü U; Akokan G
Proc Eur Dial Transplant Assoc; 1978; 15():506-14. PubMed ID: 740682
[No Abstract] [Full Text] [Related]
12. Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy.
Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Laghi Pasini F; Galeazzi M
Clin Exp Rheumatol; 2010; 28(2):290-1. PubMed ID: 20483057
[No Abstract] [Full Text] [Related]
13. Familial Mediterranean fever successfully treated with etanercept.
Mor A; Pillinger MH; Kishimoto M; Abeles AM; Livneh A
J Clin Rheumatol; 2007 Feb; 13(1):38-40. PubMed ID: 17278949
[TBL] [Abstract][Full Text] [Related]
14. [Periodic disease and the problem of amyloidosis].
Ulagay I; Dilşen N
Turk Tip Cemiy Mecm; 1968; 34(11):682-9. PubMed ID: 5733136
[No Abstract] [Full Text] [Related]
15. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
[TBL] [Abstract][Full Text] [Related]
16. A new mutation causing autosomal dominant periodic fever syndrome in a Danish family.
Weyhreter H; Schwartz M; Kristensen TD; Valerius NH; Paerregaard A
J Pediatr; 2003 Feb; 142(2):191-3. PubMed ID: 12584543
[TBL] [Abstract][Full Text] [Related]
17. [Heart involvement in patients with periodic disease and amyloidosis].
Vinogradova OM; Kochubeĭ LN; Golyzhnikov VA; Tomas NIu; Eventov AZ; Pisareva NA
Ter Arkh; 1992; 64(9):81-6. PubMed ID: 1481162
[No Abstract] [Full Text] [Related]
18. Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement.
Minden K; Aganna E; McDermott MF; Zink A
Ann Rheum Dis; 2004 Oct; 63(10):1356-7. PubMed ID: 15361406
[No Abstract] [Full Text] [Related]
19. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
Dinc A; Erdem H; Rowczenio D; Simsek I; Pay S; Bahce M; Lachmann H
J Nephrol; 2005; 18(5):626-9. PubMed ID: 16299693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
